Paracoccidioidomycosis Induced by Immunosuppressive Drugs in a Patient with Rheumatoid Arthritis and Bone Sarcoma: Case Report and Review of the Literature

Mycopathologia

Volumn 172, Issue 1, 2011, Pages 77-81

  Woyciechowsky, Tiago G ^a   Dalcin, Diogo C ^a   dos Santos, José Wellington A ^a   Michel, Gustavo T ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Bone sarcoma; Immunosuppressive drugs; Paraccocidioides brasiliensis; Paracoccidioidomycosis; Rheumatoid arthritis; TNF blocking agents

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BONE TUMOR; CASE REPORT; CHEMICALLY INDUCED DISORDER; FATALITY; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; ISOLATION AND PURIFICATION; LUNG; LUNG TUMOR; MALE; METASTASIS; MICROBIOLOGY; MIDDLE AGED; PARACOCCIDIOIDES; PATHOLOGY; POSTOPERATIVE COMPLICATION; RHEUMATOID ARTHRITIS; SARCOMA; SEPSIS; SOUTH AMERICAN BLASTOMYCOSIS; SOUTH AND CENTRAL AMERICA;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ARTHRITIS, RHEUMATOID; BONE NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LATIN AMERICA; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; POSTOPERATIVE COMPLICATIONS; SARCOMA; SEPSIS;

PARACOCCIDIOIDES BRASILIENSIS;

EID: 79960570030     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9403-0     Document Type: Article

References (21)

1. Castón-Osorio JJ, Rivero A, Torres-Cisneros J. Epidemiology of invasive fungal infection. Int J Antimicrob Agents. 2008; 32(Suppl. 2): 103-9.
2. Shikanai-Yasuda MA, Telles Filho FQ, Mendes RP, Colombo AL, Moretti ML. Guidelines in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2006; 39(3): 297-310.
3. Londero AT, Santos JW, Silva LA, Ramos CD. Paracoccidioidomicose induzida por droga imunssupressora em paciente com lúpus eritrematoso sistêmico. Arq Bras Med. 1988; 62(3): 185-7.
4. Santos JW, Andrade CF, Lopes TSA, Londero AT. Pseudotumoral presentation of chronic pulmonary paracoccidioidomycosis: report of a case. Mycopathologia. 1996; 134: 135-6.
5. Shikanai-Yasuda MA, Conceição YMT, Kono A, Rivitti E, Campos AF, Campos SV. Neoplasia and paracoccidioidomycosis. Mycopathologia. 2008; 165: 303-12.
6. Braun J, Rau R. An update on methotrexate. Curr Opin Rheumatol. 2009; 21(3): 216-23.
7. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: a systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006; 295(19): 2275-85.
8. Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregui A, Calabozo M, Quintana A. Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet Disord. 2008; 9(52): 1-27.
9. Benard G, Kavakama J, Mendes-Giannini MJ, Kono A, Duarte AJ, Shikanai-Yasuda MA. Contribution to the natural history of paracoccidioidomycosis: identification of the primary pulmonary infection in the severe acute form of the disease-a case report. Clin Infect Dis. 2005; 40: 1-4.
10. Trad HS, Trad CS, Junior JE, Muglia VF. Revisão Radiológica de 173 Casos Consecutivos de Paracoccidioidomicose. Radiol Bras. 2006; 39(3): 175-9.
11. Severo LC, Palombini BC, Utz E, Braun SN. Paracoccidioidomicose pulmonar resultante de reativação de lesão quiescente, em paciente imunossuprimido. J Pneumolog. 1980; 6(1): 21-2.
12. Borgia G, Reynaud L, Cerini R, Ciampi R, Schioppa O, Dello Russo M, Gentile I, Piazza M. A case of paracoccidioidomycosis: experience with long-term therapy. Infection. 2000; 28(2): 119-20.
13. Marchiori E. Aspectos radiológicos das lesões osteoarticulares na paracoccidioidomicose-Considerações Sobre 20 Casos. Radiol Bras. 1989; 22: 5-16.
14. Wanke B. Paracoccidioidomicose: Inquérito Intradérmico com Paracoccidioidina em Zona Urbana do Município do Rio de Janeiro. Tese à Faculdade de Medicina, Universidade Federal do Rio de Janeiro. 1976: 16-17.
15. Severo LC, Londero AT, Geyer GR, Porto NS. Acute pulmonary paracoccidioidomycosis in an immunosuppressed patient. Mycopathologia. 1979; 68(3): 171-4.
16. Sugar AM, Restrepo A, Stevens DA. Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis. 1984; 129: 340-2.
17. Shikanai-Yasuda MA, Duarte MI, Nunes DF, Lacaz CS, Sabagga E, Abdala E, Duarte AJ, Lopes MH. Paracoccidioidomycosis in a renal transplant recipient. J Med Vet Mycol. 1995; 33: 411-4.
18. Zavascki AP, Bienardt JC, Severo LC. Paracoccidioidomycosis in organ transplant recipient: case report. Rev Inst Med Trop Sao Paulo. 2004; 46(5): 279-81.
19. Wallis SR. Infectious complications of tumor necrosis factor blockade. Curr Opin Infec Dis. 2009; 22: 402-9.
20. Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumor necrosis factor-α inhibitor therapy. Drugs. 2009; 69(11): 1403-15.
21. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicanting tumor necrosis factor α blockade therapy. Mayo Clin Proc. 2008; 83(2): 181-94.